• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONCORD MANUFACTURING 2008T HEMODIALYSIS SYS., WITH CDX DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONCORD MANUFACTURING 2008T HEMODIALYSIS SYS., WITH CDX DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 190713
Device Problem Fluid Leak (1250)
Patient Problems Syncope (1610); Fatigue (1849); Low Blood Pressure/ Hypotension (1914); Nausea (1970); Blurred Vision (2137); Vomiting (2144); Blood Loss (2597)
Event Date 03/18/2019
Event Type  Injury  
Manufacturer Narrative
Clinical investigation: a temporal relationship exists between hd therapy utilizing the 2008t hemodialysis sys and the patient¿s serious adverse event(s) of nausea, vomiting, blurred vision, fatigue, lightheadedness, hypotension and blood loss. The etiology of the hypotension is unknown; therefore, causality cannot be firmly established. However, intradialytic hypotension occurs in approximately 25% of all hd treatments, and is the most frequently observed complication of hd therapy. The patient¿s nausea, vomiting, blurred vision, fatigue and lightheadedness can reasonably be attributed to the underlying hypotension. The blood loss was caused from discontinuing treatment and initiating another. Based on the information available, the 2008t hemodialysis sys cannot be disassociated from the event(s) as there is insufficient evidence to exclude the 2008t hemodialysis sys from a causal or contributory role. Fresenius was not contacted to provide servicing, and no machine service/repair records were made available. As such, no assessment regarding the machine¿s functionality during the event(s) can be completed. Additionally, it is also unknown to what extent the leaking, tmp alarms and/or blood leak detected alarm contributed to the event(s).
 
Event Description
On (b)(4) 2019 fresenius was made aware this (b)(6) female patient with end stage renal disease (esrd) on hemodialysis (hd) thrice weekly for renal replacement therapy (rrt) experienced nausea, vomiting, blurred vision, fatigue, lightheadedness, hypotension and blood loss during hd therapy on (b)(6) 2019. During follow-up, the patient¿s registered nurse (rn) stated the clinic staff noticed the 2008t hemodialysis sys leaking unspecified fluid from the rear of the machine, accompanied by a transmembrane pressure (tmp) alarm. Subsequently the patient complained of nausea, blurred vision and lightheadedness. The patient was given 500ml of normal saline (ns) and was transferred to another hd machine to complete hd therapy. The rn reported a blood leak alarm occurred after the patient was disconnected from the 2008t hemodialysis sys. The patient lost approximately 100 ml of blood due to the event. Machine records and additional information was requested; however, the request was declined. The rn stated the optiflux 160 dialyzer and fresenius bloodlines were discarded following the event; however, there was no allegation of product malfunction against the dialyzer or bloodlines. The hd treatment record from (b)(6) 2019 was received by fresenius on 03/26/2019. The treatment record states, the patient arrived for their scheduled hd treatment in stable condition with no edema or pain. The patient¿s pre-treatment vital signs were: blood pressure (bp)
=
150/75 (standing), bp
=
154/73 (sitting), respiratory rate (rr)
=
16, pulse (p)
=
65. The patient¿s hd treatment was initiated at 6:04 am and remained uneventful until 8:03 am, when the patient¿s tmp alarm sounded. The patient was given 100ml of ns to clear out the venous chamber, and the patient¿s vital sign interval was set to 15 min. At 8:24 am the patient complained of nausea and lightheadedness, and upon review of the patient¿s bp, it was noted to be 69/47. The patient experienced a small emesis, after which she was placed in the trendelenburg position and given a combined total of 500ml of ns. At 8:28 am the patient¿s vital signs improved with the administration of ns and positioning changes. Bp
=
187/85, p
=
69. The record states the patient¿s blood was returned and she was transition to another hd machine, as the current 2008t hemodialysis sys was leaking and the tmp alarm was sounding (with no mention of a blood leak alarm). Following the event(s), the patient completed their 4. 0-hour treatment without additional issue. Post-treatment the patient complained of feeling ¿groggy¿ and fatigued, however she ambulated without assistance and was discharged home.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name2008T HEMODIALYSIS SYS., WITH CDX
Type of DeviceDIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
CONCORD MANUFACTURING
4040 nelson avenue
concord CA 94520
Manufacturer (Section G)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer Contact
matthew amaral
920 winter st.
waltham, MA 02451
7816999758
MDR Report Key8486635
MDR Text Key141063787
Report Number2937457-2019-01005
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K093902
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Biomedical Engineer
Type of Report Initial,Followup
Report Date 04/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator
Device Catalogue Number190713
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Device Age MO
Event Location No Information
Date Manufacturer Received04/24/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/23/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse

Patient Treatment Data
Date Received: 04/05/2019 Patient Sequence Number: 1
Treatment
FRESENIUS BLOODLINES; FRESENIUS OPTIFLUX DIALYZER
-
-